Trial intelligence / Profile preview

Combina: Oseltamivir Combinations for Influenza A

NCT00830323Phase 2Terminated

Sponsor
Hospices Civils de Lyon
Start
Jan 2009
Primary completion
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of zanamivir, amantadine in Influenza A infection, sponsored by Hospices Civils de Lyon. Started Jan 2009; status: terminated.

02

Drugs

zanamiviramantadine
03

Conditions

Influenza A infection

Beyond the preview

Go deeper on NCT00830323.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00830323.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call